1-1 of 1
Cor Lieftink
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities

Michela Serresi, Bjorn Siteur, Danielle Hulsman, Carlos Company, Matthias J. Schmitt, Cor Lieftink, Ben Morris, Matteo Cesaroni, Natalie Proost, Roderick L. Beijersbergen, Maarten van Lohuizen, Gaetano Gargiulo
Journal: Journal of Experimental Medicine
J Exp Med (2018) 215 (12): 3115–3135.
https://doi.org/10.1084/jem.20180801
Published: 28 November 2018
View article titled, Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities
Open the PDF for Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities in another window
Includes: Supplementary data